Use of methotrexate in patients with psoriatic arthritis

被引：0
|
作者：
Ceponis, A. [1 ]
Kavanaugh, A. [1 ]
机构：
[1] Univ Calif San Diego, Ctr Innovat Therapy, Div Rheumatol Allergy & Immunol, La Jolla, CA 92037 USA
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2010年 / 28卷 / 05期
关键词：
Methotrexate; psoriatic arthritis; disease modifying drugs; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; SYNOVIAL MEMBRANES; THERAPY; TRIAL; LIVER; LEFLUNOMIDE; DISEASE; RATES;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Despite a paucity of high quality clinical data, methotrexate (MTX) remains one of the most commonly used medications in the treatment of patients with psoriatic arthritis (PsA). This report addresses mechanistic rationale, available clinical evidence, safety considerations, and a potential research agenda regarding the use of MTX in the management of PsA.
引用
收藏
页码：S132 / S137
页数：6
相关论文
共 50 条
  • [31] COSTS AND BENEFITS OF METHOTREXATE IN PSORIATIC ARTHRITIS
    Deininger, K.
    Maksabedian, E.
    VALUE IN HEALTH, 2020, 23 : S371 - S372
  • [32] Psoriatic arthritis, methotrexate, and liver toxicity
    Alarcón, GS
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2001, 7 (04) : 213 - 214
  • [33] Role of Methotrexate in the Management of Psoriatic Arthritis
    Musaab Elmamoun
    Vinod Chandran
    Drugs, 2018, 78 : 611 - 619
  • [34] SPONDYLOARTHRITIS Is methotrexate effective in psoriatic arthritis?
    Mease, Philip J.
    NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (05) : 251 - 252
  • [35] Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
    Calasan, Maja Bulatovic
    van den Bosch, Oscar F. C.
    Creemers, Marjonne C. W.
    Custers, Martijn
    Heurkens, Antonius H. M.
    van Woerkom, Jan Maarten
    Wulffraat, Nico M.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [36] Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis
    Lindsey Tilling
    Sue Townsend
    Joel David
    Clinical Drug Investigation, 2006, 26 : 55 - 62
  • [37] Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
    Maja Bulatović Ćalasan
    Oscar FC van den Bosch
    Marjonne CW Creemers
    Martijn Custers
    Antonius HM Heurkens
    Jan Maarten van Woerkom
    Nico M Wulffraat
    Arthritis Research & Therapy, 15
  • [38] Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis
    Tilling, L
    Townsend, S
    David, J
    CLINICAL DRUG INVESTIGATION, 2006, 26 (02) : 55 - 62
  • [39] Discontinuation of Methotrexate or TNF Inhibitors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    George, Michael D.
    Baker, Joshua F.
    Ogdie, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [40] Risk of Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis Treated with Methotrexate
    Wan, Joy
    Zhang, He
    Ogdie, Alexis
    Egeberg, Alexander
    Gelfand, Joel M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 12 - 12
12345